Yannick Doyon

3 Patents

• US125826992026

  Compositions and Methods for Enhanced Lymphocyte-mediated Immunotherapy

  Université Laval

  0 cites
• US123785492025

  Crispr-cas9 System and Uses Thereof

  UNIVERSITÉ LAVAL

  0 cites
• US117252182023

  Artificial Nucleases Comprising Engineered Cleavage Half-domains

  Sangamo Therapeutics, Inc.

  0 cites